VNRX News and Press, VolitionRX Limited

VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...

VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting PR Newswire HENDERSON, Nev. , June 27, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a mid-year review to stockho...

2024-06-14 16:24:10 ET More on VolitionRX VolitionRx Limited (VNRX) Q1 2024 Earnings Call Transcript VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on VolitionRX Historical earnings data for VolitionRX F...

ORLANDO, FL / ACCESSWIRE / June 14, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) ("Nexalin") and VolitionRX Limited (NYSE American:VNRX) ("Volition") on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturd...

VolitionRx Limited to Present at Jefferies Global Healthcare Conference PR Newswire HENDERSON, Nevada , May 29, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced today that Cameron Reynol...

2024-05-14 20:24:06 ET VolitionRx Limited (VNRX) Q1 2024 Results Conference Call May 14, 2024 8:30 AM ET Company Participants Cameron Reynolds - President, CEO Terig Hughes - CFO Andrew Retter - CMO Gael Forterre - CCO Louise Batchelor - Chief Marketing &...

VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Tuesday, May 14 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , May 1...

2024-05-13 13:39:00 ET More on VolitionRX VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on VolitionRX Historical earnings data for VolitionRX Financial information for VolitionRX Read the full article...

VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Tuesday May 14 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev. , May 8, 2024 /PRNewswire/ -- VolitionRx Limite...

VolitionRx (NYSE American: VNRX) is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. ...